• home
    • CVVR Research Program
    • Clinical Trials Unit
    • Flow Cytometry Core
    • Intranet
    • Barouch
    • Dolin
    • Engelman
    • Jost
    • Koralnik
    • Reeves
    • Santra
    • Schmitz
    • Seaman
    • Stephenson
    • Tan
    • Walsh
    • Whitney
    • CVVR Academic Program
    • CVVR Seminars
    • Calendar
    • Young Investigator Committee
  • News
  • Contact
  • Events
Menu

Center for Virology and Vaccine Research

3 Blackfan Cir, 10th Floor
Boston, MA, 02115
6177354485

Your Custom Text Here

Center for Virology and Vaccine Research

  • home
  • Our Research
    • CVVR Research Program
    • Clinical Trials Unit
    • Flow Cytometry Core
    • Intranet
  • Laboratories
    • Barouch
    • Dolin
    • Engelman
    • Jost
    • Koralnik
    • Reeves
    • Santra
    • Schmitz
    • Seaman
    • Stephenson
    • Tan
    • Walsh
    • Whitney
  • Education
    • CVVR Academic Program
    • CVVR Seminars
    • Calendar
    • Young Investigator Committee
  • News
  • Contact
  • Events
IMG_1043.jpg

News

Studying Zika

May 8, 2017 Lucie Fitzgibbon
 A worker in Brazil sprays insecticides into a house to kill  Aedes aegypti  mosquitoes, which carry the Zika virus.  Photograph courtesy of Marcia Castro

A worker in Brazil sprays insecticides into a house to kill Aedes aegypti mosquitoes, which carry the Zika virus.  Photograph courtesy of Marcia Castro

By:  Matthew Disler
Harvard Magazine, May 8th, 2017

To understand the outbreak of a disease like Zika, and ultimately to fight it, researchers must work on multiple levels. There are questions of molecules and chemical processes: how does the virus infect a cell, and what components provoke an immune response that can be harnessed for treatments and vaccines? On a larger scale, there are questions about populations. How does a pathogen discovered in Uganda spread from French Polynesia to Brazil and the Caribbean? How do families and individuals cope with infants born with complications from the disease, like microcephaly (an abnormally small head size) and neurological damage, whose lasting effects still have not been fully determined? Harvard researchers have already made strides at all of these levels, and, as North America prepares for another outbreak this summer, now seek to answer further questions.

← 4 Amazing Men and Women at the Forefront of HIV WorkNew therapeutic vaccine approach holds promise for HIV remission →
Summary Block
This is example content. Double-click here and select a page to feature its content. Learn more
Featured
Latest Article
 

CVVR is a division of the Department of Medicine at Beth Israel Deaconess Medical Center, a teaching hospital of Harvard Medical School.

 

© Copyright 2016-2017, Center for Virology and Vaccine Research CVVR. All Rights Reserved